Cell-based therapies in Parkinson's disease

被引：24

作者：

Greene, Paul ^{[1
]}

机构：

[1] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA

来源：

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS | 2009年 / 9卷 / 04期

关键词：

FETAL NIGRAL TRANSPLANTATION; RANDOMIZED CONTROLLED-TRIAL; TISSUE-TRANSPLANTATION; DOPAMINERGIC-NEURONS; GROWTH-FACTOR; RAT MODEL; NERVE; NEUROPROTECTION; AUTOGRAFTS; DYSKINESIA;

D O I：

10.1007/s11910-009-0044-3

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The possibility of using stem cells to treat Parkinson's disease has excited physicians and patients alike. However, after many encouraging open-label studies of fetal cell transplantation for Parkinson's disease, three randomized, double-blind, placebo-controlled studies found no net benefit. In addition, patients in two of the studies developed dyskinesias that persisted despite reductions in medication. To realize the promise of stem cells, research has been undertaken to understand and overcome the dual problems of unpredictable benefit and troublesome dyskinesias after dopaminergic cell transplantation.

引用

页码：292 / 297

页数：6

共 49 条

[1]

Arias-Carrion Oscar, 2007, CNS & Neurological Disorders-Drug Targets, V6, P326, DOI 10.2174/187152707783220875

[2] Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease [J].

Arjona, V ;

Mínguez-Castellanos, A ;

Montoro, RJ ;

Ortega, A ;

Escamilla, F ;

Toledo-Aral, JJ ;

Pardal, R ;

Méndez-Ferrer, S ;

Martín, JM ;

Pérez, M ;

Katati, MJ ;

Valencia, E ;

García, T ;

López-Barneo, J .

NEUROSURGERY, 2003, 53 (02) :321-328

[3] Recent advances in cell-based therapy for Parkinson disease [J].

Astradsson, Arnar ;

Cooper, Oliver ;

Vinuela, Angel ;

Isacson, Ole .

NEUROSURGICAL FOCUS, 2008, 24 (3-4)

[4]

BANKIEWICZ KS, 1988, PROGR BRAIN RES, V78, P543

[5] Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats [J].

Ben-Hur, T ;

Idelson, M ;

Khaner, H ;

Pera, M ;

Reinhartz, E ;

Itzik, A ;

Reubinoff, BE .

STEM CELLS, 2004, 22 (07) :1246-1255

[6]

Bjorklund A., 1985, NEURAL GRAFTING MAMM, P3

[7] Assessing fetal nerve cell grafts in Parkinson's disease [J].

Braak, Heiko ;

Del Tredici, Kelly .

NATURE MEDICINE, 2008, 14 (05) :483-485

[8] The functional impact of the intrastriatal dopamine neuron grafts in parkinsonian rats is reduced with advancing disease [J].

Breysse, Nathalie ;

Carlsson, Thomas ;

Winkler, Christian ;

Bjorklund, Anders ;

Kirik, Deniz .

JOURNAL OF NEUROSCIENCE, 2007, 27 (22) :5849-5856

[9] Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in Parkinsonian rats [J].

Carta, Manolo ;

Carlsson, Thomas ;

Kirik, Deniz ;

Bjorklund, Anders .

BRAIN, 2007, 130 :1819-1833

[10] Bridging nigrostriatal pathway with fibroblast growth factor-primed peripheral nerves and fetal ventral mesencephalon transplant recuperates from deficits in parkinsonian rats [J].

Chiang, Yung-Hsiao ;

Lin, Shinn-Zong ;

Zhou, Feng C. .

CELL TRANSPLANTATION, 2006, 15 (06) :475-482

← 1 2 3 4 5 →